A single dose of psilocybin eased depression symptoms for months, our study found
Our trial found psilocybin worked fast and lasted months, but unpicking the drug’s true effect from patients’ expectations remains a challenge.
Primary Results
Does psilocybin really provide long‑term relief from depression, as new study suggests?
Psilocybin studies to treat mental health disorders have tended to only look at short-term results.
Psychedelics: how they act on the brain to relieve depression
The active compound in magic mushrooms seems to increase connections between different brain networks.
Lasting relief from depression after magic‑mushroom treatment – new study
Participants report life-changing effects years after psilocybin treatment.
Psychedelic drugs: how to tell good research from bad
There is a lot of hype in psychedelics research at the moment. Here’s how to tell which research is good and which isn’t.
How different mushrooms learned the same psychedelic trick
The discovery could also make the production of psilocybin in the lab more sustainable.
Being admitted to hospital after taking hallucinogens increases the risk of schizophrenia more than threefold
Hallucinogens may not be as benign a previously thought, but they are a lot less harmful than alcohol.
Brain‑altering fungi could lead the next frontier in mental health care
Psilocybin, the active ingredient in magic mushrooms, is one example of a fungus which can alter the human mind.
Why the magic mushroom anti‑ageing claims are overblown
The magic mushroom longevity study that’s too good to be true.
From trips to treatments: how psychedelics could revolutionise anti‑inflammatory medicine
Magic mushrooms and LSD may do more than bend minds: they could fight inflammation linked to depression, arthritis and heart disease.